Latest 10-Q quarterly reports
OQB
Thunder Mountain Gold, Inc. reported a net loss of $1.01 million for Q2 2026, with exploration and legal costs significantly increasing, while cash reserves declined.
SIND
Sinda LTDSinda Ltd. filed its Form 10-Q for the quarter ended June 30, 2026, detailing significant increases in exploration and administrative expenses, a substantial net loss, and the successful completion of its Initial Public Offering (IPO) and a concurrent placement with Fresnillo plc.
Family Office of America, Inc. filed its Form 10-Q for the quarter ended June 30, 2026, reporting revenues of $532,674 for the quarter and $1,315,800 for the six months, but also highlighting substantial doubt about its ability to continue as a going concern.
NASDAQ
Dogwood Therapeutics, Inc. filed its Q2 2026 10-Q, detailing increased operating expenses, a significant impairment charge, and highlighting substantial doubt about its ability to continue as a going concern.
OTC.Pink
NovelStem International Corp. reported a net loss of $140,816 for the six months ended June 30, 2026, with current liabilities significantly exceeding current assets, highlighting ongoing liquidity concerns.
BMP AI Technologies Inc. filed its Form 10-Q for the quarter ended June 30, 2026, reporting no revenue, a net loss of $18,963 for the quarter, and highlighting substantial doubt about its ability to continue as a going concern.
OTC.Pink
Patriot Gold Corp. has transitioned from a net loss to a significant net income in Q2 2026, primarily driven by the resolution of royalty payment disputes and a substantial increase in revenue.
OTC.Pink
REMSLEEP HOLDINGS, INC. reported a net loss of $393,410 for the six months ended June 30, 2026, a significant increase from the prior year, alongside a going concern warning.
OID
American Clean Resources Group, Inc. reported a net loss of $423,064 for the quarter ended June 30, 2026, and highlighted substantial doubt about its ability to continue as a going concern.
OTC.Pink
China Foods Holdings Ltd. experienced a dramatic decrease in revenue for the six months ended June 30, 2026, reporting only $255 compared to $142,255 in the prior year, while continuing to incur net losses.
NASDAQ
Jasper Therapeutics' Q2 2026 Form 10-Q reveals substantial operating losses and a precarious going concern status, offset by a recent $132 million financing and the acquisition of Kira Pharmaceuticals.
OQX
Skyline Bankshares, Inc. announced its financial results for the second quarter and first half of 2026, showcasing increased net income, loan growth, and a stable financial position.
OTC.Pink
MMTRS
Mills Music TrustMills Music Trust reports Q2 2026 cash receipts from EMI, highlighting an ongoing dispute over royalty calculation methods and a prior settlement.
CN Healthy Food Tech Group Corp. reports revenue growth but faces severe financial challenges including defaults on promissory notes and a Nasdaq delisting determination, impacting its operational future.
OID
Caro Holdings Inc. reported a significant net loss for the first quarter ended June 30, 2026, with a substantial decrease in revenue and an increase in operating expenses, while also announcing a new mineral property acquisition.
OQB
TRCK
Track Group, INCTrack Group, Inc. announces a significant turnaround in its Q3 2026 results, marked by a substantial debt reduction, a positive net income, and an improved cash position.
AEI Income & Growth Fund XXII Limited Partnership's Q2 2026 report shows a decrease in rental income and net income, with cash reserves declining.
AEI Income & Growth Fund XXI Limited Partnership reports a decrease in rental income for the first half of 2026, with net income of $110,700, as the partnership continues its liquidation process.
OQB
URSB Bancorp, Inc. announced a significant increase in net income for the second quarter of 2026, driven by robust net interest income and loan growth, alongside a successful initial public offering.
NASDAQ
LFWD
Lifeward LTDLifeward Ltd. reported a 16% revenue increase for Q2 2026 but faces substantial doubt regarding its ability to continue as a going concern due to ongoing net losses and negative cash flow.
NASDAQ
IB Acquisition Corp. reports a substantial going concern risk due to a working capital deficit and lack of liquidity, while progressing towards a business combination with GNQ Insilico Inc.
OID
SDR Drone, Inc. (formerly Hallmark Venture Group, Inc.) reports significant operational changes and a substantial accumulated deficit in its Q2 2026 filing, highlighting a critical need for future financing.
NASDAQ
Tomi Environmental Solutions announced a significant revenue increase in Q2 2026, driven by product sales, while also detailing progress on its merger with Carbonium Core, Inc. and addressing ongoing financial challenges.
NASDAQ
ELAB
Elevai Labs INCPMGC Holdings Inc. files its Q2 2026 Form 10-Q, detailing significant revenue growth from recent acquisitions but also substantial net losses and ongoing going concern uncertainties.
OTC.Pink
WinVest Acquisition Corp. reports a substantial doubt about its going concern status in its Q2 2026 10-Q filing, citing liquidity issues and an impending liquidation deadline.
NASDAQ
Skye Bioscience terminates nimacimab R&D, pauses clinical trials, and focuses on a proposed acquisition of Redx Pharma, while facing ongoing financial and listing challenges.
OTC.Pink
APYP
Appyea, INCTechlott Inc. reported a net loss of $1.87 million for Q2 2026, with significant R&D and amortization expenses, while facing substantial doubt about its ability to continue as a going concern.
THAR
Tharimmune, INCCanton Strategic Holdings, Inc. reported its second quarter 2026 financial results, highlighting new revenue from network validation and locking-as-a-service, but also significant unrealized losses on its digital asset holdings.
NASDAQ
GNPX
Genprex, INCGenprex, Inc. reports on its Q2 2026 progress, highlighting advancements in its oncology and diabetes gene therapy programs, while addressing ongoing liquidity concerns and Nasdaq compliance.
NASDAQ
Upland Software's Q2 2026 results show an 8% revenue decline, a $35.2 million goodwill impairment, and ongoing challenges with Nasdaq listing requirements.